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Functional organization of the HIV 
lipid envelope
Nerea Huarte1,*, Pablo Carravilla1,*, Antonio Cruz2, Maier Lorizate1,3, Jon A. Nieto-Garai1, 
Hans-Georg Kräusslich3, Jesús Pérez-Gil2, Jose Requejo-Isidro1 & José L. Nieva1
The chemical composition of the human immunodeficiency virus type 1 (HIV-1) membrane is critical for 
fusion and entry into target cells, suggesting that preservation of a functional lipid bilayer organization 
may be required for efficient infection. HIV-1 acquires its envelope from the host cell plasma membrane 
at sites enriched in raft-type lipids. Furthermore, infectious particles display aminophospholipids on 
their surface, indicative of dissipation of the inter-leaflet lipid asymmetry metabolically generated 
at cellular membranes. By combining two-photon excited Laurdan fluorescence imaging and atomic 
force microscopy, we have obtained unprecedented insights into the phase state of membranes 
reconstituted from viral lipids (i.e., extracted from infectious HIV-1 particles), established the role 
played by the different specimens in the mixtures, and characterized the effects of membrane-active 
virucidal agents on membrane organization. In determining the molecular basis underlying lipid packing 
and lateral heterogeneity of the HIV-1 membrane, our results may help develop compounds with 
antiviral activity acting by perturbing the functional organization of the lipid envelope.
The human immunodeficiency virus type 1 (HIV-1) is an enveloped virus that follows a membrane fusion strat-
egy to access and activate the replication cycle within the cytoplasm of host cells, typically CD4+ T cells and cells 
of the monocyte/macrophage lineage1. Host cell recognition and fusion with its plasma membrane is mediated 
by the viral envelope glycoprotein (Env)2. Furthermore, the physical properties and chemical composition of the 
HIV membrane play a key role in the entry process3,4. While much is known about the mechanistic and structural 
details of Env-mediated fusion5,6, the functional organization of membrane lipids is less well understood.
HIV-1 acquires its lipid envelope and Env proteins by assembly and budding at the plasma membrane of the 
infected cell7,8. Assembly is driven by the viral Gag polyproteins, and appears to occur in specific membrane 
microdomains7,8. Advanced mass spectrometry combined with protocols optimized for the isolation of viral 
lipids enabled the determination of the HIV-1 membrane composition9–11. These studies showed that cholesterol 
(Chol) and sphingomyelin (SM) are enriched in the virus at concentrations similar to those in detergent-resistant 
membranes9. Quantitative analyses also revealed that, as compared to the bulk plasma membrane, the viral mem-
brane appears to be enriched in specific lipids, including aminophospholipids, dihydrosphingomyelin (DHSM), 
plasmenyl phosphoethanolamine (or plasmalogen phosphatidylethanolamine, pl-PE), phosphoinositides, or cer-
amide, and this composition varied depending on the producer cell lines10–12.
In addition, mature virions have been reported to expose phosphatidylserine (PS) and phosphatidylethanola-
mine (PE) on their external surface13–17. Thus, the membrane acquired by HIV from infected cells appears to have 
lost the asymmetric lipid distribution generated at the plasma membrane by ATP-dependent aminophospholipid 
translocases. It has been suggested that PS exposure on virions and virally infected cells may enable viruses to 
evade immune recognition and diminish inflammatory responses to infection14,18. Aminophospholipids may also 
act as cofactors for HIV-1 infection of macrophages13, a phenomenon possibly related to the functional modula-
tion of viral membrane lipid packing and lateral organization3,4.
To gain insight into the molecular basis governing packing order and lateral heterogeneity in the complex 
HIV membrane, we have studied Giant Unilamellar Vesicles (GUVs) and monolayers made of lipids extracted 
from infectious HIV-112. We have quantified lipid packing in the HIV-membrane GUVs by applying modi-
fied two-photon Laurdan fluorescence microscopy, and analyzed the topographic features of the monolayers 
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by atomic force microscopy. We have compared first these complex membranes with compositionally simple 
models, identifying individual species that are critical for the maintenance of high order and lateral demixing. 
Subsequently, to assess the functional relevance of lipid order and miscibility, we have characterized the perturb-
ing effects exerted by membrane-active agents on membranes made from virus-derived lipids, correlating with 
their virucidal activity.
Our results indicate that the complex HIV membrane is highly packed, but less ordered than the rigid domains 
segregated in DOPC:SM:Chol-based models, and may display de-mixed nanoscopic lipid assemblies modulated 
by the lipid composition. Fluidification and induction of nanodomain coalescence by membrane-active com-
pounds appear to be detrimental for viral entry, and changing membrane order may thus represent an alternative 
target for antiviral development.
Results
Membrane lipid packing in HIV-1 mixtures and surrogates. To quantitatively determine HIV mem-
brane packing, we performed two-photon imaging of Laurdan-stained GUVs made from a complex mixture 
of lipids extracted from purified, infectious HIV-1 (Fig. 1). Laurdan is a hydrophobic probe highly sensitive to 
solvent polarity. Its fluorescent emission undergoes a large spectral shift due to the reorientation of solvent polar 
molecules in the fluorophore vicinity during the time it spends in its excited state19,20. When incorporated in a 
lipid bilayer, Laurdan’s spectral shift is independent of the polar head charge and is, instead, a function of the 
hydration and viscosity of the membrane, reflecting its phase state. A wavelength-ratiometric parameter called 
Generalized Polarization (GP) quantifies Laurdan’s emission spectral shift from tightly packed bilayers (hardly 
hydrated) to loosely packed (highly hydrated) membranes, thus providing an indirect measurement of mem-
brane order through packing. Laurdan GP imaging of GUVs allows direct visualization of phase-separated lipid 
domains, although its quantification is prone to artifacts and requires exquisite adjustment of the optical set-up. 
Very small deviations from a circularly polarized excitation beam result in a systematic uncertainty on the deter-
mination of the GP. Supplementary Fig. S1 illustrates this effect and our approach to identify and correct small 
polarization mismatches, thereby allowing accurate GP quantification in the complete equatorial section of the 
vesicle.
Figure 1a displays a ratiometric GP image of a GUV made of HIV lipids (micrograph on the left) and the 
average GP values determined for 4 different preparations (right panel). All reconstituted HIV membranes 
displayed a single macroscopic ordered phase with mean average GP values ranging between 0.64 ± 0.01 and 
0.68 ± 0.01. The mean value measured for the complete population (n = 228) was 0.66 ± 0.02. By comparison, the 
1,2-dioleoyl-sn-glycero-3-phosphocholine DOPC:SM:Chol (2:2:1) mixture (henceforth Ld/Lo phase-separated 
model) laterally separated in two domains: one with a GP value of 0.70 ± 0.02, corresponding to a liquid-ordered 
(Lo) phase, defined as enriched in saturated sphingolipids and cholesterol in a highly condensed state, and the 
other with a GP value 0.06 ± 0.06, corresponding to a liquid-disordered (Ld) phase, enriched in unsaturated 
glycerophospholipids in a disordered state (Supplementary Fig. S2a). These observations were consistent with an 
overall high degree of lipid packing in the viral envelope. However, the significant differences in the distribution 
of the collected GP values (Supplementary Fig. S2) further suggest that the lipid packing level of the viral mem-
brane is below that measured in the Lo domain of the phase-separated model, or in the two-component SM:Chol 
(1:1) mixture (0.71 ± 0.01, Supplementary Fig. S2b).
To identify the HIV lipid species responsible for sustaining lipid packing, Laurdan GP values were further 
determined for GUVs made from synthetic virus-like (VL) mixtures (Fig. 1b and Supplementary Table S1). 
Models combining 5 lipids (VL-2 and VL-3) have been derived from the HIV lipidome established by Brügger 
et al.9 and are commonly employed as surrogates of the viral membrane21–23. Similarly to the HIV-1 mixture, all 
VL mixtures displayed a single macroscopic phase (GP images on top). However, quantification of the GP values 
revealed significant differences in lipid packing (bottom panel).
The simpler models VL-0 and VL-1 combine a single glycerophospholipid, DOPC with SM and Chol. VL-0 
matches the GP value of the HIV membrane using a similar Chol content (ca. 45%), and DOPC and SM content 
as determined from the GP-phase diagram of the DOPC:SM:Chol ternary mixture24 (Supplementary Fig. S3). 
Thus, VL-0 embodies a simplified model of the HIV membrane displaying a comparable level of lipid packing. 
In contrast, the VL-1 mixture combines DOPC with the mole fractions of SM and Chol found in the viral lipi-
dome9–11. The Laurdan GP value determined for the VL-1 mixture was much lower than for GUVs made from 
virus-extracted lipids or VL-0. The lipid mole ratios reveal that it is the higher SM content which sustains the 
higher GP value of VL-0 in comparison to the VL-1 mixture. The GP values displayed in Fig. 1b demonstrate 
that an increase of mixture complexity to render VL-2, VL-3 and VL-4 surrogates, may emulate the ordering 
effect of SM.
The GP value of the VL-1 mixture increased significantly when replacing a fraction of DOPC by the ami-
nophospholipids DOPE and DOPS (VL-2 model21). A further increase of the GP value was observed for the 
VL-3 mixture containing 1-palmitoyl-2-oleoyl phospholipids (POPC; POPE; POPS) instead of the respective 
di-oleyl lipids. Each monounsaturated glycerophospholipid separately contributed to increased lipid packing 
(Supplementary Fig. S4a). A subtle increase of the Laurdan GP value was finally observed for GUVs made of 
the VL-4 mixture. In this case, fractions of POPE and SM were replaced with pl-PE and DHSM, respectively, 
two species that account for a significant mole percentage of virion lipids9. GUVs made of this 7-lipid mixture 
exhibited a membrane order degree comparable to that measured for GUVs made of HIV-1 lipid extracts (dotted, 
reference line).
The higher Laurdan GP values of increasingly complex mixtures indicated that HIV lipid packing primarily 
depends on polar head-group identity and acyl-chain saturation degree, while the presence of DHSM and pl-PE 
may also contribute to increase the order level as previously suggested9. Laurdan GP values displayed in Fig. 2 
further illustrate the contribution to the lipid packing of single components in the generally used VL-2 model. As 
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expected, Chol is the main determinant of membrane order (Fig. 2a). The VL-2 mixture devoid of Chol displayed 
GP values consistent with a single fluid phase. Inclusion of 15–30 mole % of Chol induced macroscopic Lo-Ld 
domain separation, while increasing its content to reach the levels existing in the viral envelope generated a sin-
gle, highly ordered phase. With 15 mol % Chol the lipid packing difference between the ordered and disordered 
phases (Δ GP) was less pronounced than in the Lo-Ld separation model (Δ GPs of 0.42 and 0.64, respectively, 
compare Fig. 2a and Supplementary Fig. S2), while this difference became even smaller with 30 mol % Chol 
(Δ GP = 0.09). These findings are consistent with recent reports indicating that subtle compositional variations 
may lead to a variety of lipid packing states in model and natural membranes25,26.
Figure 2b shows the effects of the three phospholipids SM, PE and PS, when PC was used as reference. SM 
enhanced the order level in a dose-dependent way, and above that measured for the VL-1 ternary mixture (left 
Figure 1. Lateral packing of HIV membrane using two-photon excitation fluorescence microscopy 
of Laurdan-labeled GUVs. (a) Laurdan GP imaging of a single HIV-reconstituted GUV (left), and GP 
quantification for 4 different HIV-reconstituted GUV preparations (right, #1–4). “Total” corresponds to 
the grouping of all data measured in the 4 preparations. GP value distributions were determined for single 
vesicles in a sample of size n as indicated, and mean values depicted as box-and-whisker plots (the ends of the 
whiskers represent standard deviations). (b) GP images and average values determined for viral-like membrane 
surrogates (top and bottom, respectively). The dotted line shows the mean GP value calculated for the HIV 
membrane (“Total” in the previous panel). Scale Bars correspond to 5 μ m in all micrographs; GP color scale 
limits: −0.2, 0.8. GUV lipid-compositions are summarized in Supplementary Table S1.
www.nature.com/scientificreports/
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panel). Interestingly, SM levels below those existing in the mixture were sufficient to attain maximal order. 
In line with the composition-dependent lipid packing, both, PE and PS, increased GP (right panel, see also 
Supplementary Figs S4b and S4c). These observations suggest that aminophospholipids may take part in regulat-
ing the ordered vs. disordered balance in de-mixed fluid domains27. They also imply that the loss of inter-leaflet 
asymmetry in virions emerging from infected cells does not necessarily result into more loosely packed lipid 
bilayers as previously suggested13.
Miscibility of the HIV membrane lipids. To determine the liquid-liquid immiscibility of the HIV mem-
brane (resulting from the differences in packing and dynamics of lipids in different liquid phases), Langmuir–
Blodgett films compressed to defined surface pressures (Π ) were transferred onto mica and analyzed by 
combining epifluorescence imaging and Atomic Force Microscopy (AFM) as previously described28. Figure 3a 
shows the miscibility transitions and topographic information of HIV-1 lipid films as a function of Π at both the 
microscopic and the nanoscopic lengthscales (top and bottom panels, respectively). The monolayer collapses at 
Figure 2. Membrane lateral packing dependence on the lipid components of viral mimic VL-2. (a) GP 
images (top) and average determination (bottom) with increasing amounts of Chol. Two GP values are defined 
for the laterally separated lipid compositions containing 15 and 30 mol % Chol, the upper one corresponds to 
the more ordered/dehydrated domain and the lower one to the more disordered/hydrated domain. GP color 
scale limits: −1.0, 1.0. (b) Membrane order dependence on phospholipid species, SM (left) and PC, PE and 
PS (right). Chol content was 46 mol % in all cases. The dotted lines indicate the average GP for VL-1 and VL-2 
mixtures. Conditions otherwise as in Fig. 1.
www.nature.com/scientificreports/
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Figure 3. Liquid-liquid immiscibility of the HIV membrane. (a) Epifluorescence microscopy (top) 
and AFM (bottom) images taken from a HIV mixture film compressed at the indicated surface pressures. 
In epifluorescence images, the bright background (liquid-disordered) corresponds to the fluorescence 
emission of the Rho-DOPE probe that gets excluded from the ordered domains (dark spots only observable 
at Π = 5 mN/m). Plots below AFM images display the height profiles for the trajectories indicated by the 
white lines. Monolayer collapse at Π = 30 mN/m is evidenced from the accumulation of material excluded 
from the interface (arrowheads mark white spots with heights of ca. 10 nm). Scale bars are 100 and 1 μ m in 
epifluorescence and AFM images, respectively. (b) Lateral organization of films made of the VL-2 mixture 
containing 15% of Chol (mol:mol), the DOPC:SM:Chol (2:2:1) phase-separated model, or the VL-0 surrogate 
(top, center and bottom, respectively). Epifluorescence and AFM images were obtained at fixed Π = 8 mN/m. 
Laterally de-mixed micron-size domains can be discerned by both techniques (left and center panels). At 
higher amplification AFM images disclose the different morphologies of the clusters (rightmost column). Other 
experimental conditions were as described for the previous panel. (c) Height difference between de-mixed 
domains and the surrounding lipid surface.
www.nature.com/scientificreports/
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30 mN/m, as evidenced by the partial exclusion of some material away from the interface (arrowheads). At the 
lower Π values of 20 and 10 mN/m the epifluorescence micrographs display homogeneous films, while the AFM 
analysis reveals a coarse texture and the presence of de-mixed nanoscopic domains. At 8 mN/m, strip-shaped 
domains with a rough morphology of the boundaries can be better discerned in the AFM images. Further low-
ering Π to 5 mN/m results in the coalescence of those nanodomains into larger clusters that can also be observed 
in the epifluorescence images as dark (ordered) domains in a fluorescent (disordered) background. Thus, the 
5–8 mN/m threshold seems to represent a miscibility transition pressure for the HIV mixture, in accordance with 
similar values reported for ternary mixtures containing Chol29.
Differences in lateral organization for the HIV membrane model and the Ld/Lo phase-separated model are 
suggested by the comparative epifluorescence/AFM analysis displayed in Fig. 3b. Low magnification images 
obtained at a fixed Π = 8 mN/m displayed micron-sized, round domains in films made of the VL-2 mixture con-
taining 15% Chol and in films of the DOPC:SM:Chol-based phase-separated and VL-0 models (top, center and 
bottom panels, respectively). Analyzing these films with AFM, however, which provides nanoscale resolution, 
revealed rough domain boundaries for the micron-size platforms in the VL-2 (15% Chol) mixture. In contrast, 
segregated domains in the ternary DOPC:SM:Chol mixtures exhibited smooth contours, as previously reported 
to occur in Ld/Lo phase-separated model systems30,31.
The very small size and rough morphology of the boundaries in rigid clusters of the HIV mixture are consist-
ent with the low line tension at domain interfaces that characterize lipid systems undergoing fluctuations in phase 
composition32. This coarse pattern is maintained at surface pressures below collapse of the monolayer, which 
emphasizes its relevance for the envelope organization. In contrast, the VL-0 surrogate displays an ordered back-
ground that contains laterally separated large platforms with smooth shapes. Thus, for comparable lipid packing 
degrees (identical GP values), the HIV lipid membrane and the simple VL-0 surrogate display different degrees of 
complexity regarding the lateral organization at the nanoscopic level. This suggests that model membranes based 
on 3-lipid combinations are not optimal surrogates of the HIV membrane.
As further shown in Fig. 3c, the height difference of the rigid domains relative to their surrounding fluid envi-
ronment (Δ h) correlated with their size and morphology (Fig. 3a,b). Line tension at the rims of de-mixing phases 
intensifies as Δ h increases33, thereby sustaining larger ordered domains in the VL-2 (15% Chol) sample than in 
the HIV mixture. Even higher Δ h values were observed in the DOPC:SM:Chol Ld/Lo phase-separation model 
and in the VL-0 surrogate (Fig. 3c), indicative of higher interfacial energy in these samples, which might in turn 
explain the separation into perimeter-minimizing, smoothly shaped domains.
Alteration of HIV membrane lipid packing and miscibility by membrane-active agents. To 
establish the functional relevance of the lipid packing and miscibility states accessible to the natural HIV mem-
brane, reconstituted GUVs and lipid monolayers were treated with membrane-active compounds displaying 
virucidal activity (Figs 4 and 5). Figure 4 (left panels) compiles the effects exerted on HIV lipid packing by three 
different compounds, namely: the Chol-extracting compound methyl-β -cyclodextrin (Mβ CD)34,35, the mem-
branolytic peptide CpreTM36 and the peroxyl radical generator 2,2′-Azobis(2-methyl-propionamidine) dihydro-
chloride (AAPH)37. Cell entry assays were carried out in parallel to confirm the efficacy of these compounds as 
virucides (right panels).
Laurdan-labeled HIV GUVs treated for at least 15 minutes with Mβ CD exhibited lower Laurdan GP values 
than untreated controls, indicating a decrease in lipid packing induced by this compound (Fig. 4a, right), which 
was consistent with the effect observed in Laurdan-stained virus particles12. At the end time-points of incubation, 
homogeneous phase GUVs with a low GP value co-existed with vesicles displaying lateral separation of more 
fluid and less fluid domains (see Supplementary Fig. S5 for an example of the latter). These findings give further 
support to the intrinsic capacity of the complex HIV membrane to access a variety of lipid packing states, which 
evolve modulated by the Chol content as in the surrogate mixtures (see previous Fig. 2a). Emphasizing the func-
tional relevance of this capacity, Chol extraction by Mβ CD blocks virus-cell entry34,35,38 (Fig. 4a, left).
Membranolytic, aromatic-rich, short peptides such as C5A from hepatitis C virus or CpreTM from HIV, both 
showing antiviral activity against HIV36,39, encompass an additional class of membrane-active virucidal agents40. 
As shown in Fig. 4b (left), Laurdan-labeled HIV GUVs treated with this peptide displayed a subtle, but significant 
reduction of the GP values. In these samples, the lowest GP values were measured for aggregated vesicles dis-
playing a contact diaphragm, consistent with a correlation between membrane-perturbing and fluidifying effects 
induced by the peptide. Again, the membrane-fluidifying CpreTM was virucidal for HIV (Fig. 4b, right).
Lipid oxidative damage also perturbs the HIV membrane and suppresses infectivity41,42. The effects of HIV 
lipid oxidation on lipid packing and cell entry were studied after exposure of HIV GUVs and pseudovirus parti-
cles to the free radical initiator AAPH37. Reduction of the Laurdan GP value indicated an overall fluidification of 
the membrane as a consequence of its oxidative action (Fig. 4c, left), while the pseudovirus exposure to AAPH 
inhibited cell entry (Fig. 4c, right). Contrasting our findings, the oxidative action of some compounds has previ-
ously been correlated with increased lipid packing and reduced membrane fluidity43, effects postulated to impair 
viral fusion42. To ensure that the fluidification effect observed in our samples did not pertain uniquely to the com-
plex HIV mixture, Laurdan GP values were also calculated and averaged in AAPH-treated VL-2 and VL-4 single 
GUVs. As shown in the Supplementary Fig. S6, the GP values of VL-2 GUVs decreased readily upon incubation 
with AAPH, while more stringent conditions were required to observe the same fluidifying effect in the case of 
the more packed VL-4 surrogate. To prove that lipids following our treatment were subject to similar degradative 
processes, we also determined Laurdan GP values for vesicles made of the same lipid composition used in previ-
ous studies (i.e., POPC)43. In this case the apparent discrepancy disappears as we observe higher GP values con-
sistent with an increase in lipid packing of AAPH-treated POPC vesicles. We surmise that the single-lipid POPC 
model does not reproduce the variety of lipid packing states inherent to the complex HIV membrane.
www.nature.com/scientificreports/
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Figure 4. Effect of membrane-active compounds on HIV membrane lateral packing (left panels) and 
pseudovirus cell entry (right panels). (a) Left: Samples were incubated with Mβ CD (1 mM) for 15 minutes 
before collecting GP images from Laurdan-labeled individual GUVs. The group of vesicles that displayed 
better fitting to two-component distributions is plotted using two boxes, the upper one corresponding to the 
more ordered domains and the lower one to the more disordered regions. Right: HIV-1 pseudoviruses were 
pre-attached to lysine-coated plates57 and treated with increasing concentrations of Mβ CD. After washing, 
reporter TZM-bl cells were layered on top, and entry (gene transduction) inferred from the number of total 
cells expressing GFP, as described previously39. Values represent means ± SD of three independent assays. 
(b) Samples were treated with CpreTM peptide. Average GP values were determined for GUVs treated for at 
least 15 minutes with 1 μ M peptide (left). The population of GUVs displaying membrane diaphragms were 
sorted out and measured separately. (c) Samples incubated with AAPH. GP values were determined after 
15 minutes incubation with 20 mM AAPH (left). Conditions otherwise as in the previous panels. (***p < 0.0001; 
**p < 0.001). GP color scale limits: 0, 0.9.
www.nature.com/scientificreports/
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Figure 5. Effect of membrane-active compounds on the lipid miscibility of the HIV membrane.  
(a) Epifluorescence images of HIV monolayers showing the effects of Mβ CD (1 mM), CpreTM (0.1 μ M)  
or AAPH (5 mM) as a function of the incubation time (top, middle and bottom panels, respectively). 
(b) Nanoscopic structure of disordered-like and condensed areas as determined by AFM analyses of the 
virucide-treated HIV monolayers. Panels on the right depict the change in the area percentage covered by 
ordered domains as a function of the incubation time. Conditions otherwise as in the previous Fig. 4b.
www.nature.com/scientificreports/
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Together, the observed changes in mean Laurdan GP values induced by the different virucidal agents underpin 
the correlation between decrease in HIV lipid packing (related to membrane fluidification) and antiviral activity. 
In other words, keeping a high level of envelope lipid packing seems to be crucial for the virus entry function.
The effects of the membrane-perturbing compounds on the in-plane organization of the HIV mixture were 
evaluated next (Fig. 5 and Supplementary Figs S7–S9). Epifluorescence images of monolayers treated with these 
compounds exhibited lateral de-mixing into micron-size domains (Fig. 5a), which were not observed in parallel, 
untreated controls. The morphological alterations undergone by those domains differed in the three samples. 
Round domains appeared at early times of incubation with Mβ CD (top panels). These domains disaggregated 
and mixed with the surrounding membrane at later times, as evidenced in experiments using Rho-DOPE and 
Topfluor-Chol probes to label the fluid (red) and ordered (green) domains, respectively (Supplementary Fig. S7). 
The double-label experiments also revealed the appearance of dark patches, consistent with the exclusion and/or 
extraction from membrane areas of the fluorescent probes. CpreTM, on the other hand, induced the formation 
of a network of ordered domains, disclosing embedded circular patches of disordered lipid regions at the longest 
times of incubation (middle panels). Finally, AAPH treatment resulted in the appearance of round rigid domains 
interspersed in the fluid background that remained stable over time (bottom panels).
Higher resolution AFM of fluid and ordered areas provided additional insights into the underlying mecha-
nisms of virucide-induced de-mixing of fluid domains (Fig. 5b and Supplementary Fig. S8). The AFM images of 
Mβ CD-treated samples revealed depletion of rigid nanodomains from fluid regions, and appearance of large clus-
ters of nanodomains within the ordered regions (Fig. 5b, top-left). In the latter regions nanodomains compacted 
over time until they started to extrude their contents into the surrounding membrane (Supplementary Fig. S8a). 
Consistently, the overall amount of membrane surface covered by the ordered (thicker) phase decreased at longer 
times of incubation (Fig. 5b, top-right). Thus, the observed effects are consistent with Chol depletion by Mβ CD, 
first occurring in the more disordered phase, which becomes more fluid and expands increasing rigid nanodo-
main propensity to cluster. After equilibration, Chol is also removed from the more ordered regions, which results 
in domain disaggregation (Supplementary Figs S7 and S8a).
By comparison, the CpreTM peptide did not affect the nanoscopic organization of the more fluid areas (Fig. 5b 
middle-left), but induced a significant increase of the rigid phase area (Fig. 5b middle-right and Supplementary 
Fig. S8b). In this case, the peptide seems to generate ordered patches within the fluid phase, fixing the pre-existing 
rigid domains into a continuous web that becomes more compact over time (Supplementary Fig. S8b). The 
appearance of circular fluid phase domains within these rigid platforms further suggests that they expand 
radially44, concomitant with merger and compaction. Thus, the peptide reduced the overall membrane order 
(Fig. 4b), but increased the rigid phase area (Fig. 5b). We hypothesize that this counterintuitive observation can 
be explained by the induction of membrane restructuring and lipid packing loosening in the vicinity of the pep-
tide (see our previous work45). These local perturbations could also induce rigid domain growth when evolving 
within phase boundaries, thereby affecting membrane organization at a larger scale.
Lastly, fluid areas in AAPH-treated films appeared to be depleted of separated rigid domains. The rigid 
domains again aggregated into ordered micron-size domains (Fig. 5b bottom-left and Supplementary Fig. S8c). 
Based on the effects observed for PC:SM:Chol monolayers46, it was argued that oxidized glycerophospholipids 
stabilize micron-sized domain separation by increasing the hydrophobic mismatch between Lo and Ld phases. 
The chemical modification is expected to make the Ld phase thinner resulting in augmented line tension at 
inter-domain boundaries and thus promoting the coalescence of rigid domains into energy-minimizing larger 
platforms46. The oxidized HIV mixture may follow this behavior, as inferred from the changes in Δ h values 
observed upon incubation with AAPH (Supplementary Fig. S9). Consistent with Ld phase thinning, the height 
difference (Δ h) increased with time and reached a maximum of ca. 1.1 nm concomitant with the stabilization 
of the separated domains. Interestingly however, this process appears to drive coalescence of rigid domains, 
but does not promote their formation, since the surface covered by the rigid phase remained constant (Fig. 5b 
bottom-right).
Overall, the monolayer results displayed in Fig. 5 support that, regardless of the mechanism, induction of lat-
eral de-mixing correlates with virucidal activity. This implies that regulation of liquid-liquid immiscibility plays a 
functional role in the viral entry process.
Discussion
Cryoelectron microscopy of virions reveals that a lipid membrane covers most of the HIV-1 surface in contact 
with the external medium47. Compared to the plasma membrane of producing cells, this lipid bilayer is enriched 
in Chol and aminophospholipids PS and PE9, which all appear to be accessible on the external leaflet3,13,17. Several 
findings support that these selective features are of functional relevance: (i) Chol-chelating/depleting compounds 
inhibit HIV fusion and infectivity3,38; (ii) Interaction with T-cell immunoglobulin (Ig) and mucin domain (TIM) 
proteins tether HIV-1 particles bearing surface-exposed PS to the cell surface as well as to each other, thereby 
blocking release from infected cells40; (iii) the chimeric antibody, bavituximab, used to identify and target PS 
exposed at membrane surfaces, suppresses productive HIV infection14; and (iv) cyclotide peptides that associate 
with membranes through specific binding to PE, exert virucidal activity on HIV virions16,17.
To gain insight into the molecular basis underlying the functional organization of the lipid HIV membrane, 
we have carried out a detailed study of the properties of GUVs made from infectious HIV-1 or from synthetic 
lipid mixtures regarding membrane order and domain miscibility. We have first produced homogeneous pop-
ulations of compositionally complex GUVs enriched in Chol24,48 (Figs 1 and 2), and accurately quantified lipid 
packing at the membrane (Supplementary Fig. S1). Ratiometric imaging revealed a high level of HIV mem-
brane order (Fig. 1a), which was lower than that observed for the segregated Lo phase in DOPC:SM:Chol GUVs 
(Supplementary Fig. S2).
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We have found that comparable levels of lipid packing can be attained by increasing SM content in the 
three-lipid, simplified model VL-0 (Fig. 1b and Supplementary Fig. S3). The ordering effect of SM can however 
be reproduced by incorporating aminophospholipids and saturated acyl chains to render more complex 5- and 
7-lipid VL-2, VL-3 and VL-4 surrogates (Fig. 1b and Supplementary Fig. S4). Topographic AFM analyses of HIV 
membrane monolayers reveal a coarse pattern, including de-mixed rigid nanodomains (Fig. 3a). Such pattern was 
not observed in Lo/Ld phase-separated or simplified VL-0 models (Fig. 3b). Thus, the HIV membrane composi-
tion appears to be set to optimize high levels of lipid packing and ensure lateral de-mixing. While highly packed 
membranes can contribute to stabilize the structure of the viral particle in the external medium, lateral separation 
into rigid nanodomains might be required for the cell entry function (see below).
Taken together, (i) the high membrane order (Fig. 1), (ii) the small Δ GP-s between ordered and disordered 
regions regulated by Chol (Fig. 2), (iii) the presence of de-mixed nanoscopic rigid domains (Fig. 3) and (iv) the 
broken line-boundaries separating rigid clusters from the surrounding membrane (Fig. 3), strongly suggest that 
the HIV membrane is actually set at the threshold of fluid phase de-mixing32. Consistently, small, but significant 
changes in lipid packing induced by membrane-active compounds (Fig. 4 and Supplementary Figs S5 and S6) 
strongly affected the lateral organization of the HIV membrane as inferred from changes in rigid nanodomain 
clustering and line tension observed by AFM (Fig. 5, and Supplementary Figs S7–S10). Further underpin-
ning the biological relevance of HIV-1 lipid packing and de-mixing states, the observed structural changes of 
the virus-derived membrane correlated with functional inhibition of pseudovirus by the membrane-active 
compounds.
The use of membrane-targeting virucidal compounds, altering the properties of the viral lipid membrane, 
has been proposed as a viable alternative for the development of broad-spectrum virus entry inhibitors42,49,50. 
Our data indicate that compounds that perturb the phase state of the HIV membrane by increasing fluidity or 
inducing ordered domain clustering might encompass effective virucides. Thus, in contrast to previous reports 
suggesting that virucides act by rigidifying the viral membrane42, our data indicate that fluidification of the mem-
brane may be detrimental for infectivity. We suggest that a highly packed fluid phase (i.e., enriched in Chol) is 
a prerequisite for retaining the nanoscopic sizes and convoluted perimeters of de-mixed rigid domains (Fig. 6). 
Reducing packing of the fluid phase may alter the size and clustering of rigid nanodomains and change the overall 
lipid miscibility in a way that could be incompatible with its function in viral entry (Fig. 6).
In its original form, the membrane raft hypothesis stated that molecular assemblies of lipids, laterally sepa-
rated under a variety of physiological conditions, play a functional role in cell compartmentalization of trafficking 
Figure 6. Model for the functional organization of the HIV membrane. Left: competence for entry depends 
on the presence of a highly packed fluid state and low line tension (top), which allows separation of small, 
convoluted rigid nanodomains (bottom). Membrane fusion would evolve more efficiently at the boundaries 
between those nanodomains and surrounding membrane52. Right: fluidification and/or thinning of the more 
disordered phase increases line tension (top) and promotes domain clustering (bottom). Coalescence results in 
a reduction of the separated domain perimeter available for membrane fusion. Compounds that reduce lipid 
packing could induce the transition between both states, and hence act as inhibitors of the entry function. AFM 
images covering a surface that approximates that of the viral lipid envelope correspond to untreated (left), and 
AAPH-treated viral lipid mixtures (right). The lighter color of the demixed domain in the latter sample denotes 
a larger height difference over the surrounding membrane.
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and signaling51. A recent model proposes an additional role in HIV fusion, which would occur at boundaries 
between disordered and ordered domains in both, target cell and viral membrane23,52. Our data provides evidence 
for the nanoseparation of the viral membrane, showing that lateral discontinuities may indeed exist in the highly 
ordered viral membrane, which opposes the view of the HIV lipid envelope as a laterally homogeneous Lo-like 
membrane. We have observed that fluidification of the more disordered regions and, hence, induction of ordered 
domain clustering (model in Fig. 6), interferes with viral entry. We speculate that both fluidification and cluster-
ing may affect Env function following two non-exclusive mechanisms: (i) larger rigid clusters may trap functional 
Env peplomers in distant areas of the membrane and hinder their lateral diffusion to the sites of fusion47,53,54, (ii) 
merging of small nanodomains into large clusters could reduce the ratio of boundary lipids to total domain lipids, 
which would diminish the influence of boundaries upon fusion52.
In conclusion, the use of HIV-reconstituted membranes has allowed us to gain extraordinary knowledge on 
the viral membrane at the molecular level. In this sense, the studied biophysical model systems and the reported 
effects could constitute valuable approaches with biomedical applications such as drug screening. Nonetheless, 
definitive transfer of our observations to the functional viral particles awaits the future implementation of optical 
methodologies allowing, precise, nanoscale phase measurements.
Materials and Methods
Materials. 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC), 1-palmitoyl-2-oleoylphosphatidylcholine 
(POPC), 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine (DOPE), 1-palmitoyl-2-oleoylphosphatidyletha-
nolamine (POPE), 1,2-dioleoyl-sn-glycero-3- phosphatidylserine (DOPS), 1-palmitoyl-2-oleoylphosphatidyl-
serine (POPS), cholesterol (Chol), egg sphingomyelin (SM, containing ≈ 86% N-palmitoyl SM), dodecanoyl 
dihydrosphingomyelin (DHSM), 1-(1Z-octadecenyl)-2-oleoyl-sn-glycero-3-phosphatidylethanolamine (pl-PE), 
23-(dipyrrometheneboron difluoride)-24- norcholesterol (Topflour-Chol) and N-(lissamine rhodamine B 
sulfonyl)-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (Rho-DOPE) were purchased from Avanti Polar 
Lipids (Birmingham, AL, USA). 6-dodecanoyl-2-dimethylaminonaphthalene (Laurdan) was obtained from 
Molecular Probes (Eugene, OR, USA). Phospholipid stock concentrations were determined by phosphate 
assay. 2,2′-Azobis(2-methyl-propionamidine) dihydrochloride (AAPH) and Methyl-β -cyclodextrin (Mβ CD) 
were purchased from Sigma-Aldrich (St. Louis, MO). The CpreTM peptide used in this study was synthesized 
in C-terminal carboxamide form by solid-phase methods using Fmoc chemistry, purified by reverse-phase 
high-performance liquid chromatography (HPLC), and characterized by matrix-assisted laser desorption ioniza-
tion–time-of-flight (MALDI-TOF) mass spectrometry (purity > 95%).
Virus purification and lipid extraction. Lipid extraction from infectious particles was performed as 
described12, according to the method of Bligh and Dyer55. The HIV-1 NL4–3 virus strain was harvested from 
cocultures of infected and uninfected MT-4 cells before cytopathic effects were observed. Particles were concen-
trated from cleared media by centrifugation through a cushion of 20% (wt:wt) sucrose in 150 mM NaCl, 10 mM 
Hepes, pH 7.4 and further purified by velocity gradient centrifugation on an Optiprep gradient (Axis-Shield, 
Oslo, Norway).
Preparation of giant unilamellar vesicles. Giant unilamellar vesicles (GUVs) were produced by spon-
taneous swelling of lipid films deposited on 40 μ m silica beads as described24,48. Briefly, lipid-Laurdan mixtures 
(0.125 mg total lipid) in CHCl3:CH3OH (9:1) were dried in a vacuum desiccator for 1 h to remove the organic 
solvent. The desiccated lipid was hydrated for 1 h at temperatures above the transition temperature of the mix-
ture (typically 55 or 65 °C for the mixtures with highest SM content) and subsequently subjected to 30 cycles of 
extrusion through two 0.4 μ m pore size polycarbonate filters in an Avanti Mini Extruder at 65 °C. Five microliters 
of silica beads was then mixed with 20 μ L of the LUV suspension, separated in ≈ 3 μ L drops on a teflon film, and 
vacuum-dried for 45 min. Dried beads covered with lipid were collected and transferred to a 7.5 g/L sucrose buffer 
to induce spontaneous swelling of GUVs. Finally vesicles were transferred to the observation dish in an isosmotic 
10 mM HEPES, 150 mM KCl (pH 7.4) buffer.
Multiphoton Fluorescence Microscopy. Images were acquired on a Leica TCS SP5 II microscope (Leica 
Microsystems GmbH, Wetzlar, Germany). For multiphoton imaging the sample was excited at 780 nm using 
a femtosecond-pulsed titanium-sapphire Mai-Tai Deepsee laser (Spectra-Physics, Berlin, Germany). To avoid 
photoselection, GUVs must be excited with a circularly polarized beam at the sample plane and imaged at their 
equatorial plane. A variable wave plate (Newport 5540) located at the input IR port of the microscope was used 
to compensate for the any polarization effect induced by the microscope optics and this way obtain a circularly 
polarized beam in the centre of the field of view at the sample plane (Fig. S1). GUVs were imaged through a x63 
water-immersion objective (numerical aperture, NA = 1.2) and 512 × 512 pixel images were acquired at 400 Hz 
per scan-line. The fluorescence emission was collected by non-descanned (NDD) hybrid detectors, as they offer 
higher sensitivity compared to descanned photomultipliers. The blue edge of the emission spectrum was collected 
by NDD 1 at 435 ± 20 nm and the red edge by NDD 2 at 500 ± 10 nm. Generalized Polarization (GP) measure-
ments were carried out on unilamellar GUVs.
Data and Image Analysis. GP images were calculated using in-house developed software based on 
MATLAB (MathWorks, MA, USA). After smoothing the images with a 2-pixel averaging circular filter and 
thresholding the intensity, we calculated the GP value for every pixel on the image following equation 1, where IB 
is the intensity collected by NDD 1, IR the intensity collected by NDD 2 and G is the factor that accounts for the 
relative sensitivity of the two channels, calibrated with 5 μ M Laurdan solution in pure DMSO56:
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The mean GP value for each lipid mixture was calculated after imaging and analyzing at least 30 GUVs. Two or 
more independent experiments were routinely carried out and averaged. In the case of co-existing phases in the 
same vesicle, our software allows the GP to be calculated for each domain separately.
Planar Supported Phospholipid Layers. Phospholipid monolayers were spread from chloroform/meth-
anol 9:1 (v/v) solutions onto a 5 mM Tris (pH 7.4), 150 mM NaCl subphase, in a thermostated Langmuir-Blodgett 
trough (NIMA Technologies, Coventry, United Kingdom) as previously described (39, 40). After 10 min to allow 
for solvent evaporation, monolayers were compressed at 25 cm2/min up to the desired pressure and then trans-
ferred onto a glass coverslip at 5 mm/min. Specific labeling of fluid disordered phase was attained by including 
head-group labeled Rho-DOPE (0.5 mol %) in the monolayer composition. Epifluorescence microscopy obser-
vation of the planar supported monolayers was performed with a Leica DMI 4000b fluorescence microscope 
(Leica Microsystems GmbH, Wetzlar, Germany) and a Hamamatsu Orca R-2 digital CCD camera (Hamamatsu 
Photonics, Japan). AFM images were obtained from the mica-supported films using a JPK Nanowizard II atomic 
force microscope (JPK Instruments, Germany) operated in contact mode, using silicon nitride tips with a spring 
constant of 0.1 N/m.
Cell entry assays. HIV-1 pseudoviruses were produced by transfection of human kidney HEK293T cells with 
the full-length env clone JRCSF (kindly provided by Jamie K. Scott and Naveed Gulzar, Simon Fraser University, 
BC, Canada) using calcium phosphate. Cells were co-transfected with vectors pWXLP-GFP and pCMV8.91, 
encoding a green fluorescent protein and an env-deficient HIV-1 genome, respectively (provided by Patricia 
Villace, CSIC, Madrid, Spain). After 24 h, the medium was replaced with Optimem-Glutamax II (Invitrogen 
Ltd, Paisley, UK) without serum. Two days after transfection, the pseudovirus particles were harvested, passed 
through 0.45 μ m pore sterile filters (Millex® HV, Millipore NV, Brussels, Belgium) and finally concentrated by 
ultracentrifugation in a sucrose gradient. HIV entry was determined using TZM-bl target cells (AIDS Research 
and Reference Reagent Program, Division of AIDS, NIAID, NIH, contributed by J. Kappes). HIV pseudoviruses 
diluted to a 10–15% tissue culture infectious dose in PBS were deposited onto Poly-L-Lysine-coated 96-well 
plates, and incubated at 4 °C for 40 minutes. After washing, free poly-lysine was blocked for 20 minutes by 
medium addition (%90 DMEM, %10 FBS) at 37 °C. Several dilutions of a given virucide in PBS were subse-
quently applied for 90 min at 37 °C. After three washing steps, 1,1 × 104 TZM-bl target cells were layered on top of 
immobilized virions in the presence of 30 μ g/mL DEAE-dextran (Sigma-Aldrich, St-Louis, MO). Infection levels 
after 72 hours were inferred from the number of GFP-positive cells as determined by flow cytometry using a BD 
FACSCalibur Flow Cytometer (Becton Dickinson Immunocytometry Systems, Mountain View, CA).
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